Sionna CF drug trial fails key endpoint; company halts program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Sionna CF drug trial fails key endpoint; company halts program
(NASDAQ: SION) Delayed: 7.18 +0.14 (1.99%)
Previous Close $7.04    52 Week High $ 
Open $7.27    52 Week Low $ 
Day High $7.73    P/E N/A 
Day Low $7.15    EPS $ 
Volume 1,476,842